HomeECX • FRA
add
Epigenomics AG
Previous close
€0.90
Day range
€0.87 - €0.90
Year range
€0.50 - €1.70
Market cap
792.77K EUR
Avg Volume
333.00
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.00K | — |
Operating expense | 115.50K | -63.45% |
Net income | -102.00K | 74.37% |
Net profit margin | -5.10K | — |
Earnings per share | — | — |
EBITDA | -110.50K | -613.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 764.00K | -36.70% |
Total assets | 11.86M | -1.45% |
Total liabilities | 11.86M | -41.79% |
Total equity | 0.00 | — |
Shares outstanding | 876.95K | — |
Price to book | ∞ | — |
Return on assets | -2.39% | — |
Return on capital | -2.49% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -102.00K | 74.37% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
Founded
1998
Headquarters
Website
Employees
3
